China Resources Pharmaceutical Group will kick off its initial public offering in Hong Kong in the next few days, hoping to raise up to $2 billion for investment and expansion. nKnown as CR Pharma, the drugmaker--part of the state-owned China Resources Holdings conglomerate--is hoping to sell 1.54 billion shares at between HK$8.45 and HK$10.15, with around 50% of the shares already earmarked for large institutional investors.